What Lifecycle Management Lessons Can We Learn From Pd-1 Immuno-Oncology Therapies?
Abstract
Authors
DR Carr E Anastasaki E Chriv SE Bradshaw
DR Carr E Anastasaki E Chriv SE Bradshaw
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now